Sarah Cooney is a science engagement specialist working at the intersection of harm reduction, science communication, and regulatory affairs. Through her consultancy, she works with organisations to shape and communicate reduced-risk approaches – specialising in the nicotine, tobacco, and chemical industries. Sarah spent a decade at British American Tobacco, where she managed science engagement and played a key role in advancing and defining the company’s reduced risk product strategy. She reshaped BAT’s publishing strategy, its visitor programme, and was responsible for award-winning reports that demystified complex research for diverse audiences. Her experience in making technical science accessible and relevant extends from boardrooms to consumers: bridging the gap between scientists, regulators, and the media. She also brings a wealth of editorial experience from major publishers Nature and Elsevier. She started her working life as a plant geneticist and she has been published in leading journals including Science and Genetics.
All videos (2)
The economic impacts of prohibition | #GFN26 Keynote #3
29 Jun 2026
The session will explore the economic dimensions of prohibition through a political economy lens. Drawing on data and insights from multiple markets, it considers how regulatory actions may influence consumer behaviour, demand across product categories and public perceptions. It will also examine potential fiscal effects and the dynamics of illicit trade in response to prohibition. Bringing together policy, data, and market insight, this session explores how prohibition shapes real-world outcomes for consumers, governments, and public health.
GFN.TV Rewind #6 | HARD TO ARGUE | Science Is Settling on Tobacco Harm Reduction
6 May 2026
Video originally aired on March 24th 2023.
Is the science publishing industry broken? Sarah Cooney doesn't think so. Learn more in advance of her keynote at GFN23.
Featuring:
Sarah Cooney
Scientist & Science Communicator
Former Head of Scientific Collaboration & Communication British American Tobacco, BAT
Director, Cooney Scientific Limited
@SarahCooneyMcQ